Abstract
Instructions and Submission
AMERICAN OTOLOGICAL SOCIETY, INC.
The One Hundred Forty-Fourth Annual Meeting
Sheraton Chicago Hotel & Towers
Chicago, IL
April 30 - May 1, 2011
Deadline for abstract submission: October 15, 2010
Abstract Submission Instructions: Please read all instructions carefully
before you begin your submission. Click
here to download a pdf file
of the following instructions. Failure to comply with the instructions
will disqualify your abstract submission. Please contact the AOS
Administrative Office if you have any questions prior to submitting
your abstract.
Email - segossard@aol.com
Ph: 352-751-0932
Cell: 217-414-4868
The American Otological Society accepts on-line submission of abstracts
to www.americanotologicalsociety.org.
The electronic version is not to contain any extraneous formatting
instructions.
Acknowledgment of receipt of an electronic submission will be sent
electronically from the AOS Administrator to the primary author.
Abstracts must be structured according to Otology & Neurotology Guidelines for Authors
General Format:
A concise abstract of not more than 250 words or
less is required for all original clinical and basic science contributions,
including
review articles. The AOS Program Advisory Committee reviews all abstracts.
Please do not place any identifying information in the body of the
abstract, such as referral to authorship or institution. Also,
if the research in your paper is supported by a grant, or special
financial
arrangement, this must be identified. These should be organized
according to the headings outlined below. The author(s) must accept
sole responsibility for statements in their submitted abstract.
Choose an appropriate title reflecting the content of the abstract
body. The title will appear in all publications if chosen for presentation.
Do not capitalize prepositions, a, an, the, etc. No changes to abstract
will be accepted after October 15. Do not include the author’s
name(s) in the abstract title or body of the abstract.
List all authors in proper sequence (limited to 6 individuals)
using first names, middle initials, and last names and exact designations
(i.e. MD, PhD, MS, etc.) Specify the primary author and the presenter
of the abstract. If a presenter is not specified, we will assume
the presenter will be the primary author. Please specify a corresponding
author if different than the Primary author to whom all correspondence
about the abstract will be directed.
The AOS Program Advisory Committee will require a completed manuscript
to the Otology & Neurotology Journal three weeks before the scientific
meeting. The AOS Program Advisory Committee and members of the AOS/ANS
Joint Council will review the manuscript for any commercial bias,
conflict of interest, use of commercial names and any other identifying
information that may conflict with the ACCME requirements. The
AOS Program Advisory Committee may ask you to revise submitted abstract
to enforce compliance with the ACCME requirements. Failure
to comply will disqualify your presentation from
the AOS program.
For clinical studies:
Objective: Brief, clear statement of the main goals of the investigation.
Study design: Specify the type of study-randomized, prospective double
blind; retrospective case review; etc.
Setting: Primary care vs. Tertiary referral center; ambulatory vs.
hospital; etc.
Patients: Primary eligibility criteria and key demographic features.
Intervention(s): Diagnostic, therapeutic, and/or rehabilitative.
Main outcome measure(s): The most essential criterion that addresses
the study’s central hypothesis.
Results: Include statistical measures where appropriate.
Conclusions: Include only those directly supported by data generated
from this study.
For basic science reports:
Hypothesis: Brief, clear statement of the main goals of the investigation.
Background: Concise orientation for the reader unfamiliar with this
line of investigation.
Methods: Succinct summary of techniques and materials employed.
Results: Include statistical measures where appropriate.
Conclusions: Include only those directly supported by data generated
from this study. Emphasize clinical relevance wherever possible.
For reviews and meta-analysis:
Objective: Brief, clear statement of the goals of the review.
Data sources: Specify database, search methodology, languages covered,
and time frame.
Study selection: Criteria used to select articles for detailed review.
Data extraction: Means of assessing quality, validity, and comparability
of extracted data.
Data synthesis: Specify statistical techniques used for data analysis.
Conclusions: Concise statement of primary inferences with any recommendations.
For All Human Studies: Indicate IRB Approval Number
Was outside funding provided for this research/project, if so, you
will
be asked
to name the source.
The
AOS Program Advisory Committee will not consider abstracts that
do not contain the required elements.
In order to begin the Abstract submission process, the
Primary author must complete the Conflict of Interest/Disclosure & Attestation
form electronically through the AOS website. Upon
successful completion of the COI Disclosure, you will be directly
linked to the Abstract
Submission page. As the primary author, it is your responsibility
to see that each author complies with the COI Disclosure guidelines.
To review the content of the Conflict of Interest/Disclosure & Attestation
form prior to your mandatory electronic submission, please
click here for a hard copy of the document to notify the co-authors of
their accountability to disclose.
To simplify the process, after all the author’s have reviewed
the Disclosure/Attestation, the primary author will collect disclosure
information from every author named on the abstract (limited to
6 individuals); list his or her Full name and Designation, record
their specific disclosure, if any, by marking the appropriate checkbox
for each individual.
ONLY AUTHORS NAMED ON THE ELECTRONIC DISCLOSURE WILL BE PUBLISHED
IN ANY PROGRAM MATERIAL.
Conflict
of Interest/Disclosure & Attestation form MUST be submitted electronically.
We will NOT except faxed
forms.
The Abstract submission process cannot be started
until the Conflict
of Interest/Disclosure & Attestation
form has been completed
Click
here to complete the mandatory Conflict of Interest/Disclosure & Attestation
form. or https://www.surveymonkey.com/s/aosdisclosurespring2011
Author Responsibility/Financial Disclosure/Conflict of Interest & Attestation
Form:
The American Otological Society and the AOS/ANS Joint Council,
as the ACCME Accredited CME provider, is dedicated to ensuring
that all content reflects the latest scientific evidence and provides
a balanced discussion of topics, advances, and controversies in
this specialty. The AOS and the AOS/ANS Joint Council requires
all authors to comply with the standards set forth by ACCME regarding
commercial bias and/or support. Therefore, all authors (primary
and contributing) are responsible for disclosing any potential
conflict of interest prior to consideration of presentation.
Conflict of interest of an individual has two components:
1) A financial relationship with a commercial interest (e.g., pharmaceutical
company or medical device manufacturer)
2) The opportunity to influence content of a CME activity relevant
to products and services of that commercial interest.
• Presentations cannot be focused on new product development
or services but are focused on patient-centric approaches to care.
• The author(s) agree to disclose all non-FDA approved use
of FDA approved drugs or medical devices at the time of abstract
submission
and prior to the actual oral presentation should your abstract
be selected for presentation.
In order to comply with the ACCME requirements, the primary author
and contributing authors are required to disclose any conflict
of interest or potential commercial bias at the time of abstract
submission. The primary author accepts responsibility to electronically
submit the conflict of interest/disclosure declarations from each
co-author.
The Abstract Submission page will include the following, please
be prepared to answer each question/item. It is imperative
that both the Abstract title and Primary author name is an identical
match on both the Disclosure form and the Abstract Submission page.
TITLE OF ABSTRACT: Capitalize each primary word in the
title, (do not capitalize prepositions such as a, an, the, etc.,)
use same
format for the body of the abstract. Do not include the author’s
name(s). (No changes accepted after 10/15/10)
AUTHORS: List all authors in proper sequence (numbering 1, 2, 3,
etc., if applicable) using FIRST NAMES, MIDDLE INITIALS, AND LAST
NAMES AND EXACT DESIGNATIONS. (No changes accepted after 10/15/10)
NAME, ADDRESS, TELEPHONE, FAX NUMBER, E-MAIL OF PRIMARY AUTHOR:
NAME, ADDRESS, TELEPHONE, FAX NUMBER, E-MAIL OF PRESENTER AT COSM:
IDENTIFICATION OF PROFESSIONAL PRACTICE GAPS, LEARNING OBJECTIVES, & DESIRED
RESULTS
Professional practice gaps are the variations or differences in
the practice patterns when compared to current evidence, standards
of care or clinical guidelines that are designed to provide quality
of care to patients. Describe how you translate identified professional
practice gaps into educational needs; how the need is expressed
in terms of knowledge, competence, performance and patient outcome;
what should the learners be able to apply to their profession after
they participate in the educational activity; list the desire results
in terms of changes in physician knowledge, competence, performance
and/or patient outcome.
Please identify the professional practice gaps, educational needs,
learning objectives, and desired results
Define Professional Practice Gap & Educational Needs:
Learning Objective:
Desired Result:
The following competency areas will be addressed - Please
select (any/all) competency areas your presentation will address
• Patient Care that is compassionate, appropriate, and effective
for the treatment of health problems and the promotion of health
• Medical Knowledge about established and evolving biomedical,
clinical, and cognate (e.g. epidemiological and social-behavioral)
sciences and the application of this knowledge to patient care
• Practice-Based Learning and Improvement that involves investigation
and evaluation of their own patient care, appraisal and assimilation
of scientific evidence, and improvements in patient care
• Interpersonal and Communication Skills that result in effective
information exchange and teaming with patients, their families,
and other health professionals
• Professionalism as manifested through a commitment to carrying
out professional responsibilities, adherence to ethical principles,
and sensitivity to a diverse patient population
• Systems-Based Practice as manifested by actions that demonstrate
an awareness of and responsiveness to the larger context and system
of health care and the ability to effectively call on system resources
to provide care that is of optimal value.
Abstract (250 words or less)
IRB or IACUC Approval (if applicable)
Was outside funding provided for this research/project?
If so, please name.
Copyright Transmittal: Abstracts are received
with the understanding that they are not under simultaneous consideration
by another publication and that they are original contributions
that have not been previously published. Accepted abstracts become
the permanent property of the Otology & Neurotology Journal and may not be published elsewhere without permission from Otology & Neurotology
Publication Statement: The material in this abstract,
has not been submitted for publication, published,
or presented
previously at another national or international meeting and is
not under consideration for presentation at another national or
international meeting including another COSM society. The penalty
for duplicate presentation/publication is prohibition of the author
from presenting at a COSM society meeting for a period of three
years.
*State Yes or No if this abstract has been considered for or denied
publication
and/or presented at any other Scientific meeting
Please review all instructions carefully. Failure to comply with
the instructions could delay the review of or disqualify your abstract submission.
Abstracts submitted for publication, published, presented previously or considered
for presentation at another national or international meeting may not be submitted.
Duplicate
submission to more than one COSM society will disqualify your paper.
Submitting author’s Electronic signature OR Fill
in name:
*Signature indicates author will abide by the above Copyright
and Publication statements:
American Otological Society
Administrative Office
Shirley Gossard, AOS Administrator
3096 Riverdale Rd
The Villages, FL 32162
Fax: 352-751-0696
Ph: 352-751-0932
Cell: 217-414-4868
Email: segossard@aol.com
|
